尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Millian, Craig. Insider active across 1 company, notably HLS Therapeutics Inc.. Aggregated, 5 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €8k. Activity tracked since 17 June 2026. The latest transaction was disclosed on 20 August 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Craig Millian has 3 filings in total, all 3 in the recent sample, concerning HLS Therapeutics Inc. on XTSE, where he is listed as 4 - Director of Issuer, 5 - Senior Officer of Issuer. Across the recent filings from 2026-06-17 to 2026-06-30, the reported buy amount is EUR 3886 and the reported sell amount is EUR 0, and the modal transaction nature is 56 - Grant of rights.